Vaughan Rees
Primary Faculty

Vaughan Rees

Senior Lecturer on Social and Behavioral Sciences

Center for Global Tobacco Control Research

vrees@hsph.harvard.edu

Other Positions

Director, Center for Global Tobacco Control

Center for Global Tobacco Control Research

Harvard T.H. Chan School of Public Health


Overview

Dr. Rees is Director of the Center for Global Tobacco Control, whose mission is to reduce the global burden of tobacco-related death and disease through training, research, and the translation of science into public health policies and programs. He directs the Tobacco Research Laboratory at the Harvard Chan School, where the design and potential for dependence of tobacco products are assessed. Studies examine the impact of dependence potential on product use and individual risk, to inform policy and other interventions to control tobacco harms. Current research uses conventional and innovative strategies to evaluate new and novel tobacco products. Examples of these products include modified risk tobacco products such as e-cigarettes; reduced ignition propensity cigarettes; hookah (tobacco waterpipe); and novel smokeless tobacco products such as snus. Clinical research methods are used to evaluate the influence of tobacco product design features on consumer responses, and their role in promoting initiation or maintenance of use among targeted populations. Findings have been used to inform tobacco control policy, develop resources for communicating risks of tobacco products, and to enhance understanding of factors that contribute to tobacco dependence.

Other research involves development of strategies to reduce secondhand smoke (SHS) exposure in domestic environments, with a focus on evaluating interventions for reducing domestic SHS exposure among children. Dr. Rees also leads an NIH funded study which seeks to reduce secondhand smoke exposure among children from low income and racially/ethnically diverse backgrounds. This research utilizes the principles of community based participatory research (CBPR) to develop and evaluate a cognitive behavioral intervention to help caregivers maintain a smoke free home environment. He has conducted studies on SHS emissions of tobacco waterpipe, and SHS monitoring in indoor environments, including private homes and cars.

Dr. Rees' academic background is in health psychology (substance use and dependence), and he trained at the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, Australia, and did postdoctoral training through the National Institute on Drug Abuse. He has also published research on the role of cue reactivity in tobacco and alcohol abuse and dependence; and clinical trials on interventions for alcohol and cannabis dependence.


Bibliography

In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countries.

Dorison CA, Lerner JS, Heller BH, Rothman AJ, Kawachi II, Wang K, Rees VW, Gill BP, Gibbs N, Ebersole CR, Vally Z, Tajchman Z, Zsido AN, Zrimsek M, Chen Z, Ziano I, Gialitaki Z, Ceary CD, Lin Y, Kunisato Y, Yamada Y, Xiao Q, Jiang X, Du X, Yao E, Wilson JP, Cyrus-Lai W, Jimenez-Leal W, Law W, Collins WM, Richard KL, Vranka M, Ankushev V, Schei V, Križanic V, Kadreva VH, Adoric VC, Tran US, Yeung SK, Hassan W, Houston R, Lima TJS, Ostermann T, Frizzo T, Sverdrup TE, House T, Gill T, Fedotov M, Paltrow T, Jernsäther T, Koptjevskaja-Tamm M, Hostler TJ, Ishii T, Szaszi B, Adamus S, Suter L, Habib S, Studzinska A, Stojanovska D, Janssen SMJ, Stieger S, Schulenberg SE, Tatachari S, Azouaghe S, Sorokowski P, Sorokowska A, Song X, Lewis SC, Sinkolova S, Grigoryev D, Drexler SM, Daches S, Geniole SN, Vracar S, Massoni S, Zorjan S, Sarioguz E, Izquierdo SM, Alves SG, Pöntinen S, Solas SÁ, Ordoñez-Riaño S, Ocovaj SB, Onie S, Lins S, Çoksan S, Sacakli A, Ruiz-Fernández S, Geiger SJ, FatahModares S, Walczak RB, Betlehem R, Vilar R, Cárcamo R, Ross RM, McCarthy R, Ballantyne T, Westgate EC, Afhami R, Ren D, Monteiro RP, Reips UD, Reggev N, Calin-Jageman RJ, Pourafshari R, Oliveira R, Nedelcheva-Datsova M, Rahal RM, Ribeiro RR, Radtke T, Searston R, Habte R, Zdybek P, Chen SC, Maturan PLG, Perillo JT, Isager PM, Kacmár P, Macapagal PM, Szwed P, Hanel PHP, Forbes PAG, Arriaga P, Paris B, Papachristopoulos K, Correa PS, Kácha O, Bernardo M, Campos O, Bravo ON, Galindo-Caballero OJ, Ogbonnaya CE, Bialobrzeska O, Kiselnikova N, Simonovic N, Cohen N, Nock NL, Johannes N, Albayrak-Aydemir N, Say N, Torunsky N, Van Doren N, Sunami N, Rachev NR, Majeed NM, Schmidt ND, Nadif K, Corral-Frías NS, Ouherrou N, Pantazi M, Lucas MY, Vasilev MR, Ortiz MV, Butt MM, Kabir M, Muda R, Tejada Rivera MDCM, Sirota M, Seehuus M, Parzuchowski M, Toro M, Hricova M, Maldonado MA, Marszalek M, Karekla M, Mioni G, Bosma MJ, Westerlund M, Vdovic M, Bialek M, Silan MA, Anne M, Misiak M, Grinberg M, Capizzi M, Espinoza Barría MF, Kurfali MA, Mensink MC, Harutyunyan M, Khosla M, Korbmacher M, Adamkovic M, Ribeiro MFF, Terskova M, Hruška M, Martoncik M, Voracek M, Cadek M, Frías-Armenta M, Kowal M, Topor M, Roczniewska M, Oosterlinck M, Kohlová MB, Paruzel-Czachura M, Romanova M, Papadatou-Pastou M, Lund ML, Antoniadi M, Jones MV, Ortiz MS, Manavalan M, Muminov A, Kossowska M, Friedemann M, Wielgus M, Varella MAC, Colloff MF, Bradford M, Vaughn LA, Eudave L, Vieira L, Pineda LMS, Pérez LC, Lazarevic LB, Jaremka LM, Kushnir E, Anton-Boicuk L, de Holanda Coelho GL, Ahlgren L, Levitan CA, Micheli L, Volz L, Stojanovska M, Boucher L, Samojlenko L, Delgado LGJ, Kaliska L, Warmelink L, Rojas-Berscia LM, Yu K, Wachowicz J, Desai K, Barzykowski K, Kozma L, Evans K, Kirgizova K, Agesin BE, Koehn MA, Wolfe K, Korobova T, Klevjer K, van Schie K, Vezirian K, Damnjanovic K, Thommesen KK, Schmidt K, Filip K, Grzech K, Hoyer K, Moon K, Rana K, Janjic K, Suchow JW, Kielinska J, Cruz Vásquez JE, Beitner J, Vargas-Nieto JC, Roxas JCT, Taber J, Urriago-Rayo J, Pavlacic JM, Bavolar J, Soto JA, Olofsson JK, Vilsmeier JK, Messerschmidt J, Czamanski-Cohen J, Boudesseul J, Lee JM, Kamburidis J, Zickfeld J, Miranda JF, Verharen JPH, Hristova E, Beshears JE, Ðordevic JM, Bosch J, Valentova JV, Antfolk J, Berkessel JB, Schrötter J, Urban J, Röer JP, Norton JO, Silva JR, Pickering JS, Vintr J, Uttley J, Kunst JR, Ndukaihe ILG, Iyer A, Vilares I, Ivanov A, Ropovik I, Sula I, Sarieva I, Metin-Orta I, Prusova I, Pinto I, Bozdoc AI, Almeida IAT, Pit IL, Dalgar I, Zakharov I, Arinze AI, Ihaya K, Stephen ID, Gjoneska B, Brohmer H, Flowe H, Godbersen H, Kocalar HE, Hedgebeth MV, Chuan-Peng H, Sharifian M, Manley H, Akkas H, Hajdu N, Azab H, Kaminski G, Nilsonne G, Anjum G, Travaglino GA, Feldman G, Pfuhl G, Czarnek G, Marcu GM, Hofer G, Banik G, Adetula GA, Bijlstra G, Verbruggen F, Kung FYH, Foroni F, Singer G, Muchembled F, Azevedo F, Mosannenzadeh F, Marinov E, Štrukelj E, Etebari Z, Baskin E, et al.

Affect Sci. 2022 Sep. 3(3):577-602. PMID: 36185503


News

For smokers, pandemic poses challenges, triggers

December 3, 2020 – Tobacco use has been declining for years in the U.S., but the COVID-19 pandemic threatens that progress. Vaughan Rees, director of the Center for Global Tobacco Control, discussed how the stress of the pandemic…

FDA: Tobacco pouches less risky than cigarettes

Tobacco pouches are less harmful than cigarettes—somewhat, according to the U.S. Food and Drug Administration (FDA). The FDA announced on October 22, 2019 that the pouches, sold by a Swedish company, are now officially classified as reduced risk…